Clinical trial enrollment in patients with endocrine neoplasm: Parity achievable, but cancer
ConclusionEnrollment parity of underrepresented minorities into clinical trials is achievable, although possibly cancer type-specific.
Source: The American Journal of Surgery - Category: Surgery Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Clinical Trials | Epidemiology | Gastroenterology | Neurology | Neurosurgery | Surgery | Thyroid | Thyroid Cancer